|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hypertension | |||||
| 2 | More general conditions related to this trial | ||||
| Cardiovascular Diseases | |||||
| Vascular Diseases | |||||
| 3 | Interventions listed in this trial | ||||
| Amlodipine, Losartan | |||||
| 4 | Additional drug interventions recognized in this trial | ||||
| Amlodipine | |||||
| Losartan | |||||
| 5 | More general drug interventions related to this trial | ||||
| Angiotensin II Type 1 Receptor Blockers | |||||
| Anti-Arrhythmia Agents | |||||
| Antihypertensive Agents | |||||
| Calcium Channel Blockers | |||||
| Cardiovascular Agents | |||||
| Membrane Transport Modulators | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| Vasodilator Agents | |||||
| 6 | Sponsors listed in this trial | ||||
| Ministry of Health, Labour and Welfare | |||||
| Japan Cardiovascular Research Foundation | |||||